Host cell entry receptors as pharmacological targets in respiratory viral infections: from biology to clinical translation. [PDF]
El-Kafrawy SA +4 more
europepmc +1 more source
ACE2-fused nanobody targeting a cryptic RBD epitope broadly neutralizes SARS-like viruses. [PDF]
Zeng W +10 more
europepmc +1 more source
Dose-Dependent Influence of RBD-Derived Amyloidogenic Peptides on SARS-CoV-2 Infectivity: A Cautionary Tale for Antiviral Design. [PDF]
Nikiforova MA +10 more
europepmc +1 more source
Diesel Exhaust Particles Remodel Lipid Raft-Associated Molecular Features Potentially Relevant to SARS-CoV-2 Susceptibility in A549 Cells. [PDF]
Botto L +8 more
europepmc +1 more source
Rationally Modified SARS-CoV-2 Spike Protein Impairs ACE2 Binding While Preserving Immunogenicity in Mice. [PDF]
Tamagnini E +15 more
europepmc +1 more source
Constraints on the G1/S transition pathway may favor selection of multicellularity as a passenger phenotype. [PDF]
Ducrocq TL +2 more
europepmc +1 more source
Experimental evolution of Rc-o319 sarbecovirus spike protein reveals limited ACE2 adaptability. [PDF]
Moreno-García J, Dufloo J, Sanjuán R.
europepmc +1 more source
Effects of RIM15 deletion on yeast adaptation to synthetic spruce hydrolysate. [PDF]
Vilela N +7 more
europepmc +1 more source
Nicotine and cotinine enhance SARS-CoV-2 entry through distinct but complementary mechanisms in human respiratory epithelial cells. [PDF]
Xu J +7 more
europepmc +1 more source
ACE2- and HR2-Mimetic Peptides Inhibit Replication of Two SARS-CoV-2 Variants. [PDF]
Zúñiga-Hernández ME +5 more
europepmc +1 more source

